Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LXR Biotech. -- Ignore unavailable to you. Want to Upgrade?

To: BRAVEHEART who wrote (131)	11/24/1998 7:16:00 PM
From: kathleen	Read Replies (2) \| Respond to of 154

Thanks for the info. Kathleen

To: BRAVEHEART who wrote (131)	1/3/1999 4:55:00 AM
From: BRAVEHEART	Respond to of 154

Here we are approximately six weeks later. Well LXR has performed as well as could be expected over the past few weeks. We had a nice rally with an anticipated correction. In fact the correction was actually somewhat accelerated & exaggerated because of year end tax loss selling into the correction. This in my opinion has created a buying opportunity. The stock should trade back to 1.75 with ease now that tax loss selling is through. Then I expect it to trade to say 2.25 before we see our next correction. This of course is assuming no real leaks start circulating on a partnering collaboration. If the volume increases to 100,000 share consecutive trading days I would anticipate a breakout to 2.75 before any real correction. THE TRUTH IS OUT THERE LONE WOLF